Gender differences in the age-stratified prevalence of erosive esophagitis and Barrett's epithelium in Japan

Hepato-Gastroenterology

Volumn 56, Issue 89, 2009, Pages 144-148

  Akiyama, Tomoyuki ^a   Inamori, Masahiko ^a   Akimoto, Keiko ^a   Iida, Hiroshi ^a   Mawatari, Hironori ^a   Endo, Hiroki ^a   Nozaki, Yuichi ^a   Yoneda, Kyoko ^a   Sakamoto, Yasunari ^a   Ikeda, Tamon ^a   Fujita, Koji ^a   Yoneda, Masato ^a   Takahashi, Hirokazu ^a   Goto, Ayumu ^a   Abe, Yasunobu ^a   Kirikoshi, Hiroyuki ^a   Kobayashi, Noritoshi ^a   Kubota, Kensuke ^a   Saito, Satoru ^a   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Barrett's epithelium; Erosive esophagitis; Gender

Indexed keywords

ADULT; AGED; AGING; ARTICLE; ATROPHY; BARRETT ESOPHAGUS; CONTROLLED STUDY; ESOPHAGOSCOPY; FEMALE; HIATUS HERNIA; HUMAN; INCIDENCE; JAPAN; KYPHOSIS; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; STOMACH MUCOSA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CHI-SQUARE DISTRIBUTION; ESOPHAGITIS; ESOPHAGOSCOPY; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 64949134761     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Furukawa N, Iwakiri R, Koyama T, Okamoto K, Yoshida T, Kashiwagi Y, Ohyama T, Noda T, Sakata H, Fujimoto K: Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol 1999; 34:441-444.
2. Inamori M, Togawa J, Nagase H, Abe Y, Umezawa T, Nakajima A, Saito T, Ueno N, Tanaka K, Sekihara H, Kaifu H, Tsuboi H, Kayama H, Tominaga S, Nagura H: Clinical characteristics of Japanese reflux esophagitis patients as determined by the Los Angeles classification. J Gastroenterol Hepatol 2003; 18:172-176.
3. Ollyo J-B, Monnier P, Fontolliet C, Savary M: The natural history, prevalence and incidence of reflux esophagitis. Gullet 1993; 3(suppl):3-10.
4. Falk GW: Gastroesophageal reflux disease and Barrett's esophagus. Endoscopy 2001; 33:109-118.
5. Falk GW: Barrett's esophagus. Gastroenterology 2002; 122:1569-1591.
6. Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L: The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111:85-92.
7. Sharma P: The Development and Validation of an Endoscopic Grading System for Barrett's Esophagus: The Prague C & M Criteria. Gastroenterology 2006; 131:1392-1399.
8. Kimura K, Takemoto T: An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 3:87-97.
9. Miki K, Ichinose M, Shimizu A: Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Japan. 1987; 22:133-41 (in Japanese with English abstract).
10. Endo M, Kobayashi S, Suzuki H, Takemoto T, Nakayama K: Diagnosis of early esophageal cancer. Endoscopy 1971; 2:61-66.
11. Hoshihara Y, Kogure T, Yamamoto Y: Diagnosis of short segment Barrett's esophagus. Stom Intest 1999; 34:133-139 (in Japanese with English abstract).
12. Sharma P, Morales TG, Sampliner RE: Short segment Barrett's esophagus: the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol 1998; 93:1033-1066.
13. Hamilton ST, Smith RR: The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987; 87:301-312.
14. Asaka M, Kato M, Kudo M, Katagiri M, Nishikawa K, Yoshida J, Takeda H, Miki K: Relationship of Helicobacter pylori to serum pepsinogen in an asymptomatic Japanese population. Gastroenterology 1992; 102:760-766.
15. Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N, Shiratori Y, Omata M: Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 1998; 42:338-343.
16. Peek RM Jr, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, Blaser MJ: Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Inves 1995; 71:760-770.
17. Kuipers EJ, Pirez-Pirez GI, Meuwissen SG, Blaser MJ: Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995; 87:1777-1780.
18. el-Omar E, Penman I, Dorrian CA, Ardill JE, McColl KE: Eradication Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcers. Gut 1993; 1060-1065.
19. Iijima K, Ohara S, Sekine H, Koike T, Kato K, Asaki S, Shimosegawa T, Toyota T: Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori infection. Gut 2000; 46:20-26.
20. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE: Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113:15-24.
21. Gutierrez O, Melo M, Segura AM, Angel A, Genta RM, Graham DY: Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 1997; 32:664-668.
22. Iijima K, Ohara S, Sekine H, Koike T, Kubota Y, Kato K, Asaki S, Toyota T: A new endoscopic method for gastric acid secretory testing. Am J Gastroenterol 1998; 93:2113-2118.
23. Morris JM, Lucas D, Bresler B: Role of the trunk in stability of the spine. J Bone Joint Surg AM 1961; 43:327-351.
24. Lander JE, Hundley JR, Simonton RL: The effectiveness of weight-belts during multiple repetitions of the squat exercise. Med Sci Sports Exerc 1992; 24:603-609.
25. Corley DA, Kubo A, Zhao W: Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut 2007; 56:756-762.
26. Vatanasi RV, Fantry GT, Wilson KT: Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease. Helicobacter 1988; 3:188-194.
27. Matysiak-Budnik T, Megraud F: Epidemiology of Helicobacter pylori infection with special reference to professional risk. J Physiol Pharmacol 1997; 48(suppl 4):3-17.